177 related articles for article (PubMed ID: 36798441)
1. Endothelial-to-osteoblast transition in normal mouse bone development.
Lin SC; Yu G; Lee YC; Song JH; Song X; Zhang J; Panaretakis T; Logothetis CJ; Komatsu Y; Yu-Lee LY; Wang G; Lin SH
iScience; 2023 Feb; 26(2):105994. PubMed ID: 36798441
[TBL] [Abstract][Full Text] [Related]
2. Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.
Yu G; Corn PG; Shen P; Song JH; Lee YC; Lin SC; Pan J; Agarwal SK; Panaretakis T; Pacifici M; Logothetis CJ; Yu-Lee LY; Lin SH
Cancer Res; 2022 Sep; 82(17):3158-3171. PubMed ID: 35802768
[TBL] [Abstract][Full Text] [Related]
3. Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition.
Lee YC; Lin SC; Yu G; Zhu M; Song JH; Rivera K; Pappin DJ; Logothetis CJ; Panaretakis T; Wang G; Yu-Lee LY; Lin SH
Oncogene; 2022 Feb; 41(6):757-769. PubMed ID: 34845375
[TBL] [Abstract][Full Text] [Related]
4. Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4.
Yu G; Shen P; Lee YC; Pan J; Song JH; Pan T; Lin SC; Liang X; Wang G; Panaretakis T; Logothetis CJ; Gallick GE; Yu-Lee LY; Lin SH
iScience; 2021 Apr; 24(4):102388. PubMed ID: 33981975
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment.
Yu G; Corn PG; Mak CSL; Liang X; Zhang M; Troncoso P; Song JH; Lin SC; Song X; Liu J; Zhang J; Logothetis CJ; Melancon MP; Panaretakis T; Wang G; Lin SH
bioRxiv; 2023 Dec; ():. PubMed ID: 38076845
[TBL] [Abstract][Full Text] [Related]
6. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.
Lin SC; Lee YC; Yu G; Cheng CJ; Zhou X; Chu K; Murshed M; Le NT; Baseler L; Abe JI; Fujiwara K; deCrombrugghe B; Logothetis CJ; Gallick GE; Yu-Lee LY; Maity SN; Lin SH
Dev Cell; 2017 Jun; 41(5):467-480.e3. PubMed ID: 28586644
[TBL] [Abstract][Full Text] [Related]
7. Cabozantinib Reverses Renal Cell Carcinoma-mediated Osteoblast Inhibition in Three-dimensional Coculture
Pan T; Martinez M; Hubka KM; Song JH; Lin SC; Yu G; Lee YC; Gallick GE; Tu SM; Harrington DA; Farach-Carson MC; Lin SH; Satcher RL
Mol Cancer Ther; 2020 Jun; 19(6):1266-1278. PubMed ID: 32220969
[TBL] [Abstract][Full Text] [Related]
8. Osteoblastic Factors in Prostate Cancer Bone Metastasis.
Lin SC; Yu-Lee LY; Lin SH
Curr Osteoporos Rep; 2018 Dec; 16(6):642-647. PubMed ID: 30203251
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cells activity against multiple myeloma cells is modulated by osteoblast-induced IL-6 and IL-10 production.
Uhl C; Nyirenda T; Siegel DS; Lee WY; Zilberberg J
Heliyon; 2022 Mar; 8(3):e09167. PubMed ID: 35846441
[TBL] [Abstract][Full Text] [Related]
10. Manipulation of Human Primary Endothelial Cell and Osteoblast Coculture Ratios to Augment Vasculogenesis and Mineralization.
Shah AR; Wenke JC; Agrawal CM
Ann Plast Surg; 2016 Jan; 77(1):122-8. PubMed ID: 25144419
[TBL] [Abstract][Full Text] [Related]
11. The Bony Side of Endothelial Cells in Prostate Cancer.
Peng J; Kang Y
Dev Cell; 2017 Jun; 41(5):451-452. PubMed ID: 28586639
[TBL] [Abstract][Full Text] [Related]
12. Evolution of enzymatic activity in the enolase superfamily: structure of o-succinylbenzoate synthase from Escherichia coli in complex with Mg2+ and o-succinylbenzoate.
Thompson TB; Garrett JB; Taylor EA; Meganathan R; Gerlt JA; Rayment I
Biochemistry; 2000 Sep; 39(35):10662-76. PubMed ID: 10978150
[TBL] [Abstract][Full Text] [Related]
13. Interactive endothelial phenotype maintenance and osteogenic differentiation of adipose tissue stromal vascular fraction SSEA-4
Mihaila SM; Resende MF; Reis RL; Gomes ME; Marques AP
J Tissue Eng Regen Med; 2017 Jul; 11(7):1998-2013. PubMed ID: 26510831
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
[TBL] [Abstract][Full Text] [Related]
15. Tumor imaging with multicolor fluorescent protein expression.
Yamamoto N; Tsuchiya H; Hoffman RM
Int J Clin Oncol; 2011 Apr; 16(2):84-91. PubMed ID: 21347627
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell modulation of bone marrow stromal cell osteogenic potential.
Kaigler D; Krebsbach PH; West ER; Horger K; Huang YC; Mooney DJ
FASEB J; 2005 Apr; 19(6):665-7. PubMed ID: 15677693
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38MAPK and JNK pathway.
Tian XY; Yung LH; Wong WT; Liu J; Leung FP; Liu L; Chen Y; Kong SK; Kwan KM; Ng SM; Lai PB; Yung LM; Yao X; Huang Y
J Mol Cell Cardiol; 2012 Jan; 52(1):237-44. PubMed ID: 22064324
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells.
Tsao YT; Shih YY; Liu YA; Liu YS; Lee OK
Stem Cell Res Ther; 2017 Feb; 8(1):39. PubMed ID: 28222767
[TBL] [Abstract][Full Text] [Related]
19. The cyan fluorescent protein nude mouse as a host for multicolor-coded imaging models of primary and metastatic tumor microenvironments.
Suetsugu A; Hassanein MK; Reynoso J; Osawa Y; Nagaki M; Moriwaki H; Saji S; Bouvet M; Hoffman RM
Anticancer Res; 2012 Jan; 32(1):31-8. PubMed ID: 22213285
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cells influence the osteogenic potential of bone marrow stromal cells.
Xue Y; Xing Z; Hellem S; Arvidson K; Mustafa K
Biomed Eng Online; 2009 Nov; 8():34. PubMed ID: 19919705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
